Correlation Between Lixte Biotechnology and Quoin Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Lixte Biotechnology and Quoin Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Lixte Biotechnology and Quoin Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Lixte Biotechnology Holdings and Quoin Pharmaceuticals Ltd, you can compare the effects of market volatilities on Lixte Biotechnology and Quoin Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Lixte Biotechnology with a short position of Quoin Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Lixte Biotechnology and Quoin Pharmaceuticals.
Diversification Opportunities for Lixte Biotechnology and Quoin Pharmaceuticals
-0.58 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Lixte and Quoin is -0.58. Overlapping area represents the amount of risk that can be diversified away by holding Lixte Biotechnology Holdings and Quoin Pharmaceuticals Ltd in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Quoin Pharmaceuticals and Lixte Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Lixte Biotechnology Holdings are associated (or correlated) with Quoin Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Quoin Pharmaceuticals has no effect on the direction of Lixte Biotechnology i.e., Lixte Biotechnology and Quoin Pharmaceuticals go up and down completely randomly.
Pair Corralation between Lixte Biotechnology and Quoin Pharmaceuticals
Given the investment horizon of 90 days Lixte Biotechnology Holdings is expected to generate 0.69 times more return on investment than Quoin Pharmaceuticals. However, Lixte Biotechnology Holdings is 1.45 times less risky than Quoin Pharmaceuticals. It trades about 0.19 of its potential returns per unit of risk. Quoin Pharmaceuticals Ltd is currently generating about -0.32 per unit of risk. If you would invest 230.00 in Lixte Biotechnology Holdings on November 9, 2024 and sell it today you would earn a total of 50.00 from holding Lixte Biotechnology Holdings or generate 21.74% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Lixte Biotechnology Holdings vs. Quoin Pharmaceuticals Ltd
Performance |
| Timeline |
| Lixte Biotechnology |
| Quoin Pharmaceuticals |
Lixte Biotechnology and Quoin Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Lixte Biotechnology and Quoin Pharmaceuticals
The main advantage of trading using opposite Lixte Biotechnology and Quoin Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Lixte Biotechnology position performs unexpectedly, Quoin Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Quoin Pharmaceuticals will offset losses from the drop in Quoin Pharmaceuticals' long position.| Lixte Biotechnology vs. Allarity Therapeutics | Lixte Biotechnology vs. Virax Biolabs Group | Lixte Biotechnology vs. Quoin Pharmaceuticals Ltd | Lixte Biotechnology vs. Indaptus Therapeutics |
| Quoin Pharmaceuticals vs. Revelation Biosciences | Quoin Pharmaceuticals vs. Virax Biolabs Group | Quoin Pharmaceuticals vs. Allarity Therapeutics | Quoin Pharmaceuticals vs. Biodexa Pharmaceticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Other Complementary Tools
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope |